Andrew Kolodny, M.D., is a senior scientist at the Institute for Behavioral Health at the Heller School at Brandeis University and co-director of the Opioid Policy Research Collaborative.
His primary area of focus is the prescription opioid and heroin crisis devastating families and communities across the country. He is also the executive director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics. Dr. Kolodny previously served as chief medical officer for Phoenix House, a national nonprofit addiction treatment agency, and as chair of psychiatry at Maimonides Medical Center in New York City. He began his career working for the New York City Department of Health and Mental Hygiene in the Office of the Executive Deputy Commissioner, where he helped develop and implement multiple programs, including citywide buprenorphine programs, naloxone overdose prevention programs and emergency room screening, brief intervention and referral to treatment (S.B.I.R.T.) programs for drug and alcohol misuse.